Mitochondrial dysfunction and oxidative stress in autism spectrum disorder: pharmacological insights into natural antioxidants
carotenoids (crocin/safranal), and "indirect" modulators (e.g., omega-3, folinic acid), emphasizing study quality, translational relevance, and limitations. The aim of this review is to synthesize current findings on the potential benefits of antioxidants in addressing both molecular and behavioral aspects of ASD, while also examining the link between oxidative stress and ASD. Furthermore, we discuss the role of antioxidant-based interventions in managing ASD symptoms. The review highlights the complex challenges associated with antioxidant therapies and deficiencies, emphasizing the need for a multifaceted nutritional approach particularly in children with ASD.
Authors
- Michele d’Angelo (ORCID: https://orcid.org/0000-0002-3693-840X)
- Vanessa Castelli (ORCID: https://orcid.org/0000-0002-7005-3218)
- Annamaria Cimini (ORCID: https://orcid.org/0000-0002-2737-7970)
- Erjola Bej
- Marta Sofia Scenna (ORCID: https://orcid.org/0009-0006-0959-7300)
- Patrizia Cesare
- Ilaria Persichitti
Institutions
- University of L'Aquila (IT)
- Catholic University Our Lady of Good Counsel (AL)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-04-15
- DOI
- https://doi.org/10.3389/fphar.2026.1783888
- Primary Topic
- Saffron Plant Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Università degli Studi dell'Aquila